BioCatalyst

SPT-300 — catalyst calendar

1 verified catalyst event(s) referencing SPT-300, each linked to its official source. Verified as of 2026-10-30.

Upcoming

DateEventCompanyDrugOfficial source & verification
2027-03 (month)
in 4mo
ESTIMATED
 READOUT
A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participan
Phase 2 · Major Depressive Disorder (MDD), Major Depressive Disorder With Anxious Distress
 SPTX Seaport Therapeutics, Inc. SPT-300 ClinicalTrials.gov ↗
✓ Source-checked 2026-10-30
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.